Disease | psoriasis |
Phenotype | C0011860|type 2 diabetes |
Sentences | 2 |
PubMedID- 25599394 | After controlling for major confounders, in the cross-sectional analysis psoriasis was significantly associated with type 2 diabetes (t2d, adjusted odds ratio (or)=2.36; 95% confidence interval ci=1.26-4.41) and myocardial infarction (mi, or=2.26; 95% ci=1.03-4.96). |
PubMedID- 24506139 | Objectives: to determine the effects after 16-20 weeks of treatment with a glucagon-like peptide (glp)-1 analogue on clinical severity and histopathological aspects of psoriasis in patients with type 2 diabetes, and to examine the presence of gammadelta t cells and the expression of interleukin (il)-17 in psoriasis before and after treatment. |
Page: 1